Abstract
Eighty-four patients with testicular seminoma were treated at the Northern Israel Oncology Center during the years 1968–1988. Using the staging classification of Hussey, 69 patients (82%) had Stage I, eight (10%) had Stage IIA, four (5%) had Stage IIB, one (1%) had Stage IIIA, and two (2%) had Stage IIIB disease. Sixtynine patients (82%) had classic pure seminoma, nine (11%) had anaplastic seminoma and six (7%) had spermatocytic seminoma. Seventy-four patients (88%) underwent high inguinal orchiectomy and ten (12%) had a scrotal approach. Seventy-five patients (85%) were treated with postoperative irradiation. Stage I patients received 26–30 Gy to the paraaortic and ipsilateral pelvic lymph nodes. Stage IIA patients were treated in the same manner with a boost to the involved lymph nodes. With a mean follow-up of 97 months, 65 patients (77%) are alive and well with no evidence of disease, 7 patients (8%) are dead due to disease progression. The 5-, 10-, 15-, and 20-year actuarial survival for all patients was 90%, and for early stage patients 94%. Eight patients (14%) relapsed; 3 of them were salvaged by chemotherapy.
Serious side effects of irradiation included lethal respiratory failure due to bleomycin-induced pulmonary fibrosis in one patient, peptic ulcer in three patients, hydronephrosis due to paraureteral fibrosis in one patient and recurrent paralytic ileus in one patient. Eight patients (10%) developed nine second cancers, three of them within the previous radiation field.
It is concluded that appropriate planning and adequate radiation dose can yield a 20-year disease-free survival rate for more than 90% of patients with early stage testicular seminoma. Accurate staging may prevent overtreatment, thus reducting long-term toxicity. Because of the risk of developing a second primary cancer, careful follow-up monitoring with a high index of suspicion for such disorders is warranted.
Similar content being viewed by others
References
Peckham, M. J.: Testicular tumours: Investigation and staging classification. In: M. J. Peckham (ed.), The Management of Testicular Tumours. Edward Arnold Ltd., London 1981, pp. 89–101.
Sommer, K., Brockmann, W. P., Hubener, K. H.: Treatment results and acute and late toxicity of radiation therapy for testicular seminoma.Cancer, 66, 259 (1990).
Hunter, M., Peschel, R. E.: Testicular seminoma. Results of the Yale University experience, 1964–1984.Cancer, 64, 1608 (1989).
Hussey, D. H.: Testis. In: G. H. Fletcher (ed.): Textbook of Radiotherapy. Lea and Febiger, Philadelphia 1980, pp. 867–886.
Stein, M., Steiner, M., Kuten, A., Cohen, J., Robinson, E.: Testicular seminoma: Results of treatment at the Northern Israel Oncology Center.Oncology, 43, 89 (1986).
Hussey, D. H.: Testicular cancer. In: Levitt, S. H., Khan, F. M., Potish, R. A. (eds.): Levitt and Tapley’s Technological Basis of Radiation Therapy: Practical Clinical Applications (2nd Ed). Lea and Febiger, Philadelphia/London 1992, pp. 323–335.
Kaplan, E. L., Meier, P.: Non-parametric estimation from incomplete observations.J. Am. Stat. Assoc., 53, 457 (1958).
Einhorn, L. H., Donohue, J. P.: Cis-diamminedichloroplatinum, Vinblastine and Bleomycin combination chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87, 293 (1977).
Cionini, L., Ciatt, S., Pitrioli, L., Santoni, R., Cappellini, M.: Radiotherapy of seminoma of the testis. Report on 129 patients.Tumori, 64, 183 (1978).
Thomas, G. M., Sturgeon, J. F., Alison, R., Jewett, M., Goldberg, L., Sugar, L., Rideout, D., Gospodarowicz, M. K., Duncan, W. A.: Study of post-orchidectomy surveillance in Stage I testicular seminoma.J. Urol., 142, 313 (1989).
Zagars, G. K., Babaian, R. J.: Stage I testicular seminoma: Rationale for post-orchidectomy radiation therapy.Int. J. Rad. Oncol. Biol. Phys., 13, 155 (1987).
Bobba, V. S., Mittal, B. B., Hoover, S. V., Kepka, A.: Classical and anaplastic seminoma: Difference in survival.Radiology, 167, 849 (1988).
Epstein, B. E., Order, S. E., Zinreich, E. S.: Staging, treatment and results in testicular seminoma: A 12-year report.Cancer, 65, 405 (1990).
Crawford, E. D., Smith, R. B., deKernion, J. B.: Treatment of advanced seminoma with pre-radiation chemotherapy.J. Urol., 129, 752 (1983).
Thomas, G. M.: Controversies in the management of testicular seminoma.Cancer, 55, 2296 (1985).
Hamilton, C., Horwich, A., Easton, D., Peckham, M. J.: Radiotherapy for Stage I seminoma testis: Results of treatment and complications.Radiother. Oncol., 6, 115 (1986).
Thomas, G. M., Rider, W. D., Dembo, A. J., Cummings, B. J., Gospodarowicz, M., Hawkins, N. V., Herman, J. G., Keen, C. W.: Seminoma of the testis: Results of treatment and patterns of failure after radiation therapy.Int. J. Rad. Oncol. Biol. Phys., 8, 165 (1982).
Lederman, G. S., Herman, T. S., Jockelson, M., Silver, B. J., Chaffey, J. T., Garnick, M. B., Richie, J., Sheldon, T. A., Coleman, C. N.: Radiation therapy of seminoma: 17-year experience at the Joint Centre for Radiation Therapy.Radiother. Oncol., 14, 203 (1989).
Hellbardt, A., Mirimanoff, R. O., Obradovic, M., Mermillod, B., Panmier, J. P.: The risk of second cancer in patients treated for testicular seminoma.Int. J. Rad. Oncol. Biol. Phys., 18, 1327 (1990).
Hay, J. H., Duncan, W., Kerr, G. R.: Subsequent malignancies in patients irradiated for testicular tumours.Br. J. Radiol., 57, 597 (1984).
Hamilton, C., Horwich, A., Bliss, M. J.: Gastrointestinal morbidity of adjuvant radiotherapy in Stage I malignant teratoma of the testis.Radiother. Oncol., 10, 85 (1987).
Coia, L. R., Hanks, G. E.: Complications from large-field intermediate dose infradiaphragmatic radiation: An analysis of the patterns of care outcome studies for Hodgkin’s disease and seminoma.Int. J. Rad. Oncol. Biol. Phys., 15, 29 (1988).
Prosnitz, L. R.: Radiation complications for Hodgkin’s disease and seminoma: Assessing the risk: benefit ratio.Int. J. Rad. Oncol. Biol. Phys., 15, 239 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stein, M., Steiner, M., Moshkowitz, B. et al. Testicular seminoma: 20-year experience at the Northern Israel Oncology Center (1968–1988). International Urology and Nephrology 26, 461–469 (1994). https://doi.org/10.1007/BF02768019
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02768019